Help Convince Washington State to Cover Genicular Nerve RFA

While nearly half of the Washington State Health Care Authority’s Health Technology Clinical Committee (HTCC) members acknowledged the value of genicular nerve radiofrequency ablation, they have nevertheless proposed to deny coverage of this beneficial knee osteoarthritis treatment. On February 7^th, IPSIS reiterated support  for coverage and again provided the committee with a concise summary of the evidence base.

You can help patients suffering from knee osteoarthritis in Washington State. Make your voice heard by submitting comments to shtap@hca.wa.gov by close of business on February 20. If you live in Washington State, IPSIS strongly encourages you to attend the next HTCC meeting on May 17 to stand up for your patients and community.